Answers are grounded in this paper and cite their sources.
Systematic review finds SDF-1α gene-activated scaffolds enhance angiogenesis in vitro, suggesting future applications in tissue engineering.
Stromal cell‐derived factor‐1α (SDF‐1α) is a potent stem cell recruitment chemokine that can promote angiogenesis, particularly when delivered via gene‐activated scaffolds (GAS). This systematic review and meta‐analysis synthesized in vitro evidence on the angiogenic potential of SDF‐1α GAS. Four databases were utilized to search for eligible studies, comprising investigations that examined the in vitro effects of SDF‐1α GAS on angiogenesis‐related outcomes compared with gene‐free scaffolds. Data on gene expression, protein levels, and endothelial formation were extracted. Meta‐analyses were conducted using random or fixed‐effect models, expressed as standardized mean difference (SMD) or mean difference (MD) with 95% confidence intervals (CI). Risk of bias was assessed using the Quality Assessment Tool for In Vitro Studies (QUIN) tool. Eight studies were included. Pooled analysis demonstrated SDF‐1α GAS efficacy to significantly increase SDF‐1α gene expression (SMD = 1.20; 95% CI = 0.13–2.27; p = .03), fold‐change of the gene (MD = 12.48; 95% CI = 10.33–14.64; p < .0001), and protein production (MD = 0.29 ng/mL; 95% CI = 0.14–0.43 ng/mL; p = .0001). Most studies showed a moderate risk of bias. Based on in vitro studies, SDF‐1α GAS activity is associated with significant elevation of SDF‐1α gene expression and protein quantity, although it did not exhibit significant enhancement of VEGF expression or functional endothelial morphogenesis under the studied conditions.
No takes yet. Share an insight, caveat, or question.
Umar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: